Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Telocytes in the scalp may help with skin regeneration and maintenance.

Stem cells from elderly skin can become neurons, offering potential for brain therapy.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Connective tissue nevi have distinct features, and reflectance confocal microscopy is useful for early diagnosis.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Anti-CD19 therapy may help treat SLE and NMOSD.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Skin stem cells help create protective immune cells during wound healing.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.